Drug Type Small molecule drug |
Synonyms canrenone, Canrenone (USAN), RP-11614 + [2] |
Target |
Mechanism MR modulators(Mineralocorticoid receptor modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization- |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date- |
Regulation- |
Molecular FormulaC22H28O3 |
InChIKeyUJVLDDZCTMKXJK-WNHSNXHDSA-N |
CAS Registry976-71-6 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hypertension | - | - | - |
Phase 4 | Hypertension Add-on | 175 | uvqvqjvswl(ccqkdzqzau) = wvohzdvrxe yrybnndnzs (gncthegbjy ) View more | - | 01 Feb 2017 | ||
uvqvqjvswl(ccqkdzqzau) = zbbczkrbfk yrybnndnzs (gncthegbjy ) View more | |||||||
Phase 3 | - | riczhgynsp(lkrzhejegh) = vkyzdfbqdy czzkqjplxd (edyzwdnrfq ) View more | - | 01 Jan 2009 | |||
Placebo | riczhgynsp(lkrzhejegh) = kmsvqskcru czzkqjplxd (edyzwdnrfq ) View more | ||||||
Phase 3 | 467 | (dgyfetiilt) = xwncrkihpe cbdsrcmfkq (pdtxxpepyz ) View more | - | 01 Sep 2007 | |||
Placebo | (dgyfetiilt) = hxpwblamze cbdsrcmfkq (pdtxxpepyz ) View more |